I. Cagnan Et Al. , "Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation.," ISSCR 2013 , pp.37-38, 2013
Cagnan, I. Et Al. 2013. Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation.. ISSCR 2013 , 37-38.
Cagnan, I., KONU KARAKAYALI, Ö., AERTS KAYA, F. S. F., Kuskonmaz, B., ÇETİNKAYA, F. D., & ÖZCAN, A., (2013). Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation. . ISSCR 2013 (pp.37-38).
Cagnan, Ilgin Et Al. "Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation.," ISSCR 2013, 2013
Cagnan, Ilgin Et Al. "Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation.." ISSCR 2013 , pp.37-38, 2013
Cagnan, I. Et Al. (2013) . "Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation.." ISSCR 2013 , pp.37-38.
@conferencepaper{conferencepaper, author={Ilgin Cagnan Et Al. }, title={Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation.}, congress name={ISSCR 2013}, city={}, country={}, year={2013}, pages={37-38} }